CCL2 and cancer: To summarise, cancer cells frequently secrete IL-1 and TGF-β which switch MSC to a pro-inflammatory phenotype (85, 86), and the monocyte chemotactic protein-1 (MCP-1) which stimulates MSC migration (87).